Print Page   Close Window

Press Release

POZEN Announces Plans to Webcast Second-Quarter Earnings Conference Call

CHAPEL HILL, N.C., Jul 24, 2002 (BW HealthWire) -- POZEN Inc. (Nasdaq: POZN), a pharmaceutical development company with a portfolio of product candidates for the treatment of migraine, today announced its plan to conduct a conference call following the release of financial results for the second quarter ended June 30, 2002.

The company will release earnings before the market opens on Thursday, August 1, 2002. John R. Plachetka, Pharm.D., POZEN's chairman, president and chief executive officer, and Matthew E. Czajkowski, chief financial officer, will host the conference call the same day at 11:00 a.m. Eastern time.

The conference call will be simulcast live on the Internet, and can be accessed by logging on to www.pozen.com. A replay will be available for seven days in the Investor Relations section of the company's website.

POZEN is a pharmaceutical development company committed to building a portfolio of products with significant commercial potential in select therapeutic areas. POZEN's initial focus is on developing products for migraine therapy, a global market expected to exceed $2.8 billion this year. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN".

POZEN is on the Internet at www.pozen.com.

Matt Czajkowski
Chief Financial Officer
Lisa Barthelemy
Director, Investor Relations